Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 11,000 shares at $27.00 ($299K) on 2009-09-14, disclosed to the SEC on 2010-05-05.
Open-market sale of $299k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 1,000 | $27K | 9.0% |
| 2 | $27.00 | 5,000 | $135K | 45.1% |
| 3 | $27.47 | 5,000 | $137K | 45.9% |
| Total | $27.21 avg | 11,000 | $299K | 100% |
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-07-21 | $461K | — | Filing → |